Search

Your search keyword '"LaRue M"' showing total 319 results

Search Constraints

Start Over You searched for: Author "LaRue M" Remove constraint Author: "LaRue M"
319 results on '"LaRue M"'

Search Results

1. An Examination of Culturally Relevant Pedagogy in a High School

2. Advances in remote sensing of emperor penguins: first multi-year time series documenting trends in the global population

3. Efficacité et sécurité de la dapsone dans le purpura thrombopénique immunologique. Résultats d’un essai multicentrique randomisé, contrôle par placebo et d’un essai émulé mono bras dans le registre Carmen

6. Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases

8. Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: A multicenter retrospective study of 59 cases

12. B381 A modified energy DTM™ SCS therapy: 6-month outcomes of a prospective, multi-center study on patients with chronic back and leg pain

17. Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group

19. Folliculotropic T-cell infiltrates associated with B-cell chronic lymphocytic leukaemia or MALT lymphoma may reveal either true mycosis fungoides or pseudolymphomatous reaction: seven cases and review of the literature

20. BASELINE CIRCULATING TUMOUR DNA AND TOTAL METABOLIC TUMOUR VOLUME AS EARLY OUTCOME PREDICTORS IN AGGRESSIVE B‐CELL LYMPHOMA. A REAL LIFE PROSPECTIVE 112‐PATIENT COHORT

21. CIRCULATING TUMOR DNA LOAD AND TOTAL METABOLIC TUMOR VOLUME IN DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) PATIENTS TREATED BY R‐CHOP – FROM REMARC, A LYSA STUDY

22. Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936

23. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936

24. EARLY CTDNA CLEARANCE AFTER CAR T‐CELL INFUSION PREDICTS OUTCOME IN PATIENTS WITH LARGE B‐CELL LYMPHOMA : RESULTS FROM ALYCANTE, A PHASE 2 LYSA STUDY.

27. EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations

28. Minimal residual disease (MRD) is a predictor of clinical outcome in elderly patients with MCL and identifies patients with long lasting remissions after R-CHOP or R-FC induction followed by maintenance with rituximab or IFN: first results of the randomized EU-MCL elderly trial: V115

30. Les auteurs

38. A study looking at different types of severe rashes called acute exanthemas

39. 一项探讨称不同类型重度皮疹(急性皮疹)的研究

40. Acute exanthemas: a prospective study of 98 adult patients with an emphasis on cytokinic and metagenomic investigation

41. PS1312 QPCR, MFC AND DDPCR: COMPARISON ON MRD SAMPLES FROM THREE PROSPECTIVE TRIALS OF THE EUROPEAN MCL NETWORK

42. OBINUTUZUMAB PLUS DHAP FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) PLUS OBINUTUZUMAB MAINTENANCE PROVIDES A HIGH MRD RESPONSE RATE IN UNTREATED MCL PATIENTS. RESULTS OF LYMA‐101 TRIAL, A LYSA GROUP STUDY

43. CLINICAL, IMMUNOPHENOTYPIC AND GENETIC CHARACTERISTICS OF AGGRESSIVE (NON-BURKITT) B-CELL LYMPHOMA IN A REAL LIFE COHORT

44. S103 OBINUTUZUMAB PLUS DHAP FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION PLUS OBINUTUZUMAB MAINTENANCE PROVIDES A HIGH MRD RESPONSE RATE IN UNTREATED MCL PATIENTS, LYMA-101 TRIAL - A LYSA TRIAL

47. READY OR NOT, HERE I COME! COMPARING TRANSITION SKILLS AND KNOWLEDGE OF TEENS WITH CHRONIC CONDITIONS

Catalog

Books, media, physical & digital resources